Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme

Ruth E. Langley, Mahesh Parmar, Trinh Duong et al.|The Lancet|2021

Cited by 49